Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

2 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 1000

Undiagnosed Disease Network Study Results, Plasma lipidomics and metabolomics

ABSTRACT: The deposited data were collected from 148 patients and 133 family members accepted into the Undiagnosed Diseases Network (https://undiagnosed.hms.harvard.edu/). The NIH Common Fund Undiagnosed Diseases Network (UDN) seeks to provide diagnoses for individuals with undiagnosed disease. Here, we report and provide the mass spectrometry-based metabolomics (GC-MS) and lipidomics (LC-MS/MS) analyses of blood plasma from 148 patients and 133 family members. We have deposited mass spectrometry-based metabolomics and lipidomics files including instrument files, normalized data processed files to allow for statistical analysis, and metabolomics and lipidomics results for each patient and associated relatives. In addition, as part of the mass spectrometry data made available, we have included mass spectrometry analyses and results from a reference population of individuals with no known metabolic diseases. UDN patients suffer from undiagnosed diseases and thus are typically represented as a sample size of one; therefore, understanding normal variation within a proband's condition needs to be measured against of dataset of normal individuals, which is included here.

INSTRUMENT(S): LTQ Velos ETD, Agilent GC 7890A coupled with a single quadrupole MSD 5975C

ORGANISM(S): Homo Sapiens

SUBMITTER: Thomas Metz

PROVIDER: MSV000084716 | MassIVE | Tue Dec 17 12:31:00 GMT 2019

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Undiagnosed Disease Network Study Results, Urine lipidomics and metabolomics

Project description:The deposited data were collected from 148 patients and 133 family members accepted into the Undiagnosed Diseases Network (https://undiagnosed.hms.harvard.edu/). The NIH Common Fund Undiagnosed Diseases Network (UDN) seeks to provide diagnoses for individuals with undiagnosed disease. Here, we report and provide the mass spectrometry-based metabolomics (GC-MS) and lipidomics (LC-MS/MS) analyses of urine from 148 patients and 133 family members. We have deposited mass spectrometry-based metabolomics and lipidomics files including instrument files, normalized data processed files to allow for statistical analysis, and metabolomics and lipidomics results for each patient and associated relatives. In addition, as part of the mass spectrometry data made available, we have included mass spectrometry analyses and results from a reference population of individuals with no known metabolic diseases. UDN patients suffer from undiagnosed diseases and thus are typically represented as a sample size of one; therefore, understanding normal variation within a proband's condition needs to be measured against of dataset of normal individuals, which is included here.

2019-12-17 | MSV000084717 | MassIVE

Undiagnosed Disease Network Study Results, CSF lipidomics and metabolomics

Project description:The deposited data were collected from 148 patients and 133 family members accepted into the Undiagnosed Diseases Network (https://undiagnosed.hms.harvard.edu/). The NIH Common Fund Undiagnosed Diseases Network (UDN) seeks to provide diagnoses for individuals with undiagnosed disease. Here, we report and provide the mass spectrometry-based metabolomics (GC-MS) and lipidomics (LC-MS/MS) analyses of cerebrospinal fluid from 148 patients and 133 family members. We have deposited mass spectrometry-based metabolomics and lipidomics files including instrument files, normalized data processed files to allow for statistical analysis, and metabolomics and lipidomics results for each patient and associated relatives. In addition, as part of the mass spectrometry data made available, we have included mass spectrometry analyses and results from a reference population of individuals with no known metabolic diseases. UDN patients suffer from undiagnosed diseases and thus are typically represented as a sample size of one; therefore, understanding normal variation within a proband's condition needs to be measured against of dataset of normal individuals, which is included here.

2019-12-17 | MSV000084715 | MassIVE

GNPS - Undiagnosed Disease Network Study Results, Urine lipidomics and metabolomics

2019-12-17 | MSV000084717 | GNPS

GNPS - Undiagnosed Disease Network Study Results, Plasma lipidomics and metabolomics

Project description:The deposited data were collected from 148 patients and 133 family members accepted into the Undiagnosed Diseases Network (https://undiagnosed.hms.harvard.edu/). The NIH Common Fund Undiagnosed Diseases Network (UDN) seeks to provide diagnoses for individuals with undiagnosed disease. Here, we report and provide the mass spectrometry-based metabolomics (GC-MS) and lipidomics (LC-MS/MS) analyses of blood plasma from 148 patients and 133 family members. We have deposited mass spectrometry-based metabolomics and lipidomics files including instrument files, normalized data processed files to allow for statistical analysis, and metabolomics and lipidomics results for each patient and associated relatives. In addition, as part of the mass spectrometry data made available, we have included mass spectrometry analyses and results from a reference population of individuals with no known metabolic diseases. UDN patients suffer from undiagnosed diseases and thus are typically represented as a sample size of one; therefore, understanding normal variation within a proband's condition needs to be measured against of dataset of normal individuals, which is included here.

2019-12-17 | MSV000084716 | GNPS

GNPS - Undiagnosed Disease Network Study Results, CSF lipidomics and metabolomics

Project description:The deposited data were collected from 148 patients and 133 family members accepted into the Undiagnosed Diseases Network (https://undiagnosed.hms.harvard.edu/). The NIH Common Fund Undiagnosed Diseases Network (UDN) seeks to provide diagnoses for individuals with undiagnosed disease. Here, we report and provide the mass spectrometry-based metabolomics (GC-MS) and lipidomics (LC-MS/MS) analyses of cerebrospinal fluid from 148 patients and 133 family members. We have deposited mass spectrometry-based metabolomics and lipidomics files including instrument files, normalized data processed files to allow for statistical analysis, and metabolomics and lipidomics results for each patient and associated relatives. In addition, as part of the mass spectrometry data made available, we have included mass spectrometry analyses and results from a reference population of individuals with no known metabolic diseases. UDN patients suffer from undiagnosed diseases and thus are typically represented as a sample size of one; therefore, understanding normal variation within a proband's condition needs to be measured against of dataset of normal individuals, which is included here.

2019-12-17 | MSV000084715 | GNPS

GNPS - Undiagnosed Disease Network Study Results, CSF lipidomics and metabolomics

Project description:The deposited data were collected from 148 patients and 133 family members accepted into the Undiagnosed Diseases Network (https://undiagnosed.hms.harvard.edu/). The NIH Common Fund Undiagnosed Diseases Network (UDN) seeks to provide diagnoses for individuals with undiagnosed disease. Here, we report and provide the mass spectrometry-based metabolomics (GC-MS) and lipidomics (LC-MS/MS) analyses of cerebrospinal fluid from 148 patients and 133 family members. We have deposited mass spectrometry-based metabolomics and lipidomics files including instrument files, normalized data processed files to allow for statistical analysis, and metabolomics and lipidomics results for each patient and associated relatives. In addition, as part of the mass spectrometry data made available, we have included mass spectrometry analyses and results from a reference population of individuals with no known metabolic diseases. UDN patients suffer from undiagnosed diseases and thus are typically represented as a sample size of one; therefore, understanding normal variation within a proband's condition needs to be measured against of dataset of normal individuals, which is included here.

2020-05-29 | MSV000085506 | GNPS

GNPS - Undiagnosed Disease Network Study Results, Plasma lipidomics and metabolomics

Project description:The deposited data were collected from 148 patients and 133 family members accepted into the Undiagnosed Diseases Network (https://undiagnosed.hms.harvard.edu/). The NIH Common Fund Undiagnosed Diseases Network (UDN) seeks to provide diagnoses for individuals with undiagnosed disease. Here, we report and provide the mass spectrometry-based metabolomics (GC-MS) and lipidomics (LC-MS/MS) analyses of blood plasma from 148 patients and 133 family members. We have deposited mass spectrometry-based metabolomics and lipidomics files including instrument files, normalized data processed files to allow for statistical analysis, and metabolomics and lipidomics results for each patient and associated relatives. In addition, as part of the mass spectrometry data made available, we have included mass spectrometry analyses and results from a reference population of individuals with no known metabolic diseases. UDN patients suffer from undiagnosed diseases and thus are typically represented as a sample size of one; therefore, understanding normal variation within a proband's condition needs to be measured against of dataset of normal individuals, which is included here.

2020-05-29 | MSV000085508 | GNPS

YangziChen2024 - Metabolic Machine Learning Predictor Model for Diagnosis of Gastric Cancer

Project description:The paper "Metabolomic Machine Learning Predictor for Diagnosis and Prognosis of Gastric Cancer" addresses the need for non-invasive diagnostic tools for gastric cancer (GC). Traditional methods like endoscopy are invasive and expensive. The authors conducted a targeted metabolomics analysis of 702 plasma samples to develop machine learning models for GC diagnosis and prognosis. The diagnostic model, using 10 metabolites, achieved a sensitivity of 0.905, outperforming conventional protein marker-based methods. The prognostic model effectively stratified patients into risk groups, surpassing traditional clinical models. I have successfully reproduced the diagnosis model from the paper. This machine learning-based system differentiates GC patients from non-GC controls using metabolomics data from plasma samples analyzed by liquid chromatography-mass spectrometry (LC-MS). The model focuses on 10 metabolites, including succinate, uridine, lactate, and serotonin. Employing LASSO regression and a random forest classifier, the model achieved an AUROC of 0.967, with a sensitivity of 0.854 and specificity of 0.926. This model significantly outperforms traditional diagnostic methods and underscores the potential of integrating machine learning with metabolomics for early GC detection and treatment.

2024-07-23 | MODEL2407230001 | BioModels

YangziChen2024 - Metabolic Machine Learning Predictor Model for Diagnosis of Gastric Cancer

2024-07-23 | MODEL2407230001 | BioModels

Mouse lung tissue transcriptome response to influenza H5N1 [miRNA] (AmbryGenetics)

Project description:The purpose is to obtain samples for mRNA, miRNA, proteomics, lipidomics, metabolomics, and histopathology analysis in mouse lung infected with WT A/Vietnam/1203/2004 (H5N1; 'VN1203').

2015-09-05 | GSE72365 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data